Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C - Wikidata - awgldk - TriplyDB

Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C

Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C

http://www.wikidata.org/entity/Q28365937

about

Limitations and opportunities of non-invasive liver stiffness measurement in children.Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?Automated image analysis method for detecting and quantifying macrovesicular steatosis in hematoxylin and eosin-stained histology images of human livers Highly effective techniques in computerized dental tissue morphometry.Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers.Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy.Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery Clinical implications of non-steatotic hepatic fat fractions on quantitative diffusion-weighted imaging of the liver.Development of a computational high-throughput tool for the quantitative examination of dose-dependent histological features.Evaluation of liver fibrosis: a concise review.Hepatitis C virus-induced hepatocellular steatosis.Stereological Analysis of Liver Biopsy Histology Sections as a Reference Standard for Validating Non-Invasive Liver Fat Fraction Measurements by MRI Relationship between clinical and pathologic findings in patients with chronic liver diseases.Hepatitis C and steatosis: a reappraisal.Hepatitis C virus (HCV) infection and hepatic steatosis Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.2,3,7,8-Tetrachlorodibenzo-p-Dioxin Alters Lipid Metabolism and Depletes Immune Cell Populations in the Jejunum of C57BL/6 Mice Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting.Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP).Desmoplasia measured by computer assisted image analysis: an independent prognostic marker in colorectal carcinoma.Comparing morphometric, biochemical, and visual measurements of macrovesicular steatosis of liver.Quantifying hepatic steatosis - more than meets the eye.Measuring liver triglyceride content in mice: non-invasive magnetic resonance methods as an alternative to histopathology.Development and evaluation of an open source Delphi-based software for morphometric quantification of liver fibrosis Morphometric analysis of hepatic steatosis in chronic hepatitis C infection.Morphometric assessment of liver fibrosis may enhance early diagnosis of biliary atresia.Comparative assessment of liver fibrosis by computerized morphometry in naïve patients with chronic hepatitis B and C.Automated quantification of steatosis: agreement with stereological point counting.Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters.Quantitative measurement of hepatic portal perfusion by multidetector row CT with compensation for respiratory misregistration.Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B.Evaluation of the spontaneous reversibility of carbon tetrachloride-induced liver cirrhosis in rabbits.Study of liver in HBV-related hepatocellular carcinoma: Stereology shows quantitative differences in liver structure

P2860

Q30360182-7E51AEE6-DCE9-4F20-98C9-D4B350BAB462 Q30369757-5423FA53-F652-458A-B110-012226F4EED9 Q30571749-10BEF66E-9278-4988-AC99-2DA64E92D960 Q30889126-288681DF-D8BF-401B-8F7E-7232C748FF37 Q33867515-8BCCE34C-683F-4165-8074-8D83F0AD8820 Q34021973-B06A50AD-B3EF-4453-B960-96693195D67E Q34091393-11A75AA4-4D17-4CE2-B5AB-43AAF21132A9 Q35088301-1CCCFA8D-10C5-47D4-A2E2-6E2F14073E6C Q35243721-DA62A4F1-E092-479F-AE45-40D8C9821470 Q35794328-13427C43-F8BA-4D6C-825F-621B16AEC057 Q36060022-26B64418-2D80-4177-A4ED-A43D984177FB Q36097591-335A1C8E-9224-4FCF-89BF-F3E285692DCD Q36180551-4363C02D-9040-4847-934B-35ED05D29777 Q36377276-54B0997E-B98E-4E81-8A96-C3AE4C0B0E1C Q36449231-679E747E-3FF0-4C95-A5B5-C1DAA0366F88 Q36503299-5082DC16-46DB-4008-9AD0-D9237D7E98DD Q37228134-198D0BC3-A1B6-4998-B631-76FA9831F541 Q38442605-FED63B75-7B1F-43FC-99FE-0F80A14A7EAF Q39631188-D663F54A-26BC-4325-9A85-F24CB038B842 Q39703910-04192A57-F558-4FE5-AF73-C558154C063C Q39960383-24E1D286-698C-492F-80DE-FE25F4DEBE42 Q40023832-877AFD43-7205-4238-8EB4-8430ED7AAA2C Q40147031-3189A9EF-7CC9-4B03-85C9-DD7E9D5159BE Q42733686-95F903AB-00A0-4461-A442-A0AEE015E4A4 Q43104807-5DB9C745-BBA7-4736-838D-42223BC303B2 Q43453815-640F7167-C6F6-43CD-9176-AB216D0A5239 Q45145149-A55AAD9F-A0F5-403F-B467-D00F076E2FCD Q47141193-45A01DDE-73FE-45AA-A860-3F951FBA0FF2 Q47299129-C5DCAE6F-98C7-4C46-9FAD-5E6D05A4D1C0 Q47921711-C5DF691E-0818-4372-A62C-196AA4AADCC6 Q50780787-B356F737-953D-49AB-80F5-B54BF603B169 Q54640463-DA3DF4D8-4170-4B13-BEE2-A641FE63DDBD Q58722160-B94FE6CA-6020-46F9-9BEA-9C03279FA9DE

P2860

Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C

http://www.wikidata.org/entity/Q28365937

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Quantitative assessment of fib ...... ients with chronic hepatitis C

@ast

Quantitative assessment of fib ...... ients with chronic hepatitis C

@en

Quantitative assessment of fib ...... ients with chronic hepatitis C

@nl

type

label

Quantitative assessment of fib ...... ients with chronic hepatitis C

@ast

Quantitative assessment of fib ...... ients with chronic hepatitis C

@en

Quantitative assessment of fib ...... ients with chronic hepatitis C

@nl

prefLabel

Quantitative assessment of fib ...... ients with chronic hepatitis C

@ast

Quantitative assessment of fib ...... ients with chronic hepatitis C

@en

Quantitative assessment of fib ...... ients with chronic hepatitis C

@nl

P1433

Q28365937-C4CEA862-16E1-41A5-A483-9485437754A6

P1476

Q28365937-31F4740F-EE8F-418D-BDF4-6F951A12C81C

P2093

Q28365937-14B629FF-D295-4FDC-82AB-CBDD7CAEF471

Q28365937-21B1BD1E-FC18-4BA7-ADEF-CDE77DB5DBA8

Q28365937-2F46E138-9208-4F9E-9658-0F4B6C02D570

Q28365937-5B5507B3-67FC-48DA-92F4-7FC9EB40224E

Q28365937-8703B5E5-6BEA-42D9-A09C-F8C0F27113F6

Q28365937-CBD33916-23F8-4352-91F0-E5DF0926B836

P2860

Q28365937-015905A0-8F24-4270-AD41-94A9C70E46CE

Q28365937-08E42D99-C7B8-40F1-8DFB-05624DD2C427

Q28365937-161D6136-D160-453E-BDC1-2DF95352092A

Q28365937-26971F01-E0BA-459C-B166-A7BA402FB5DB

Q28365937-4675CFF2-BB75-40C5-8AA2-E260DFD3FF4A

Q28365937-51C42D64-213D-4266-8411-4E89B942350C

Q28365937-6D91C395-1605-4C56-BB14-780456EF94ED

Q28365937-72FB2A35-BC6F-4981-AF65-0ED6E52CE475

Q28365937-83EF0C3E-7573-4D68-A77F-40BF07AEEE4D

Q28365937-871F1A5B-EA48-4E7C-BDC2-870AEBD749E9

P304

Q28365937-DD71FA2E-EC3C-4D5C-AFDD-8CD29A248FF9

P31

Q28365937-13895ADA-1412-4C61-B105-72B04E7DD271

P3181

Q28365937-73E68F90-23C6-4FFE-B6ED-AAD6184D0329

P356

Q28365937-22AF020A-28D1-4E14-960A-E7F851942D8F

P407

Q28365937-27FE2576-B5C8-4526-8B6A-FCB6E11737A2

P433

Q28365937-23C96045-A1C9-4FFE-8813-41D970500AEF

P478

Q28365937-51A6AEF3-9E21-4F83-AC72-14AB68FA2484

P577

Q28365937-1512247F-C433-4B13-9260-6269E42344D9

P5875

Q28365937-A51FE523-D830-4597-BE9F-E3451743663A

P698

Q28365937-BEC29E52-C374-4517-8122-B4C94C71FEE4

P921

Q28365937-F094D9C7-DEC5-4566-A29E-B7DB9025E045

P932

Q28365937-A018DE22-68FD-4894-8515-4B9F5C7CBC24

P3181

P356

P1433

Journal of Clinical Pathology

P1476

Quantitative assessment of fib ...... ients with chronic hepatitis C

@en

P2093

A M Zaitoun

http://www.w3.org/2001/XMLSchema#string

C O Record

http://www.w3.org/2001/XMLSchema#string

H Al Mardini

http://www.w3.org/2001/XMLSchema#string

S Awad

http://www.w3.org/2001/XMLSchema#string

S Makadisi

http://www.w3.org/2001/XMLSchema#string

S Ukabam

http://www.w3.org/2001/XMLSchema#string

P2860

Serum collagen type IV for the assessment of fibrosis and resistance to interferon therapy in chronic hepatitis C

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

Histological grading and staging of chronic hepatitis

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

Computer morphometry for quantitative measurement of liver fibrosis: comparison with Knodell's score, colorimetry and conventional description reports.

Quantitative aspects of the parenchyma-stroma relationship in experimentally induced cholestasis.

Histological features predictive of liver fibrosis in chronic hepatitis C infection

Liver fibrosis: perspectives in pathobiochemical research and clinical outlook.

Chronic viral hepatitis B and C: an argument against the conventional classification of chronic hepatitis.

P304

461-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4298786

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/JCP.54.6.461

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11962486

http://www.w3.org/2001/XMLSchema#string

P698

11376020

http://www.w3.org/2001/XMLSchema#string

P921

P932

1731453

http://www.w3.org/2001/XMLSchema#string